Objective: To determine the chemical constituents and antimicrobial activity of the hexane leaf extract of Anisopus mannii against a wide range of human pathogenic microorganisms.
Methods: The chemical constituents of the hexane leaf extract was determined using gas chromatography-mass spectrometry (GC-MS) analysis; and the antimicrobial activity was evaluated on clinical susceptible and resistant bacterial and fungal isolates using the disc diffusion and broth micro dilution methods.
Results: GC-MS analysis of the hexane leaf extract revealed 32 compounds, representing 73.8% of the identified components. The major compounds were hexadecanoic acid, ethyl ester (34%), oxirane, hexadecyl- (11%) and 9, 12, 15-octadecatrienoic acid, ethyl ester, (Z, Z, Z) (9.6%). Results from the antimicrobial activity demonstrated higher inhibition zones against B. cereus (29 mm), followed by S. pyogenes (28 mm). Other notable inhibitions were observed with E. faecalis (27 mm), P. vulgaris (26 mm) and MRSA (25 mm). The MIC values ranged from 0.625 mg/mL to 1.25 mg/mL while the MBC/MFC values ranged from 2.5 mg/mL to 5.0 mg/mL.
Conclusion: These results support the traditional use of the plant and demonstrate the huge potential of A. mannii as a source of antimicrobial compounds.
Anisopus mannii, hexane extract, GC-MS, antimicrobial activity
Improving cell transplantation by understanding and manipulating the phagocytic activity of peripheral glia.
Nazareth L, St John J, Ekberg J
Neural regeneration research. 2022; 17(2): 313-314
Significance of mitochondrial activity in neurogenesis and neurodegenerative diseases.
Ozgen S, Krigman J, Zhang R, Sun N
Neural regeneration research. 2022; 17(4): 741-747
Genotypic Distribution and Antimicrobial Susceptibilities of Carbapenemase-Producing Isolated From Rectal and Clinical Samples in Korean University Hospitals Between 2016 and 2019.
Jeong S, Lee N, Park MJ, Jeon K, Kim HS, Kim HS, Kim JS, Song W
Annals of laboratory medicine. 2022; 42(1): 36-46
Turbidity-Based MIC Assay and Characterization of Spontaneous Drug Resistant Mutants in Mycobacterium ulcerans.
Thomas SS, Kalia NP, Pethe K
Methods in molecular biology (Clifton, N.J.). 2022; 2387(): 209-217
In Vitro Assessment of Drug Activity Against Mycobacterium ulcerans.
Komm OD, Almeida DV, Converse PJ, Nuermberger EL
Methods in molecular biology (Clifton, N.J.). 2022; 2387(): 189-194